30 closest matches · ranked by relevance
Heart Failure · Pulmonary Disease, Chronic Obstructive · Emphysema
Primary: Function Assessment of Chronic Illness Therapy-General (FACT-G) — 59.0; 54.0 score on a scale
Critical Illness · Oncology · Communication
Primary: Change in Prognostic Understanding — 0.58; 0.18 units on a scale
Critical Illness · Oncology · Communication
Primary: Acceptability of the Proposed Intervention According to a Structured Qualitative Survey of Caregivers — 9; 10; 1; 3 Participants
Cancer Terminal
Primary: Dignity Impact Scale — 26.3; 26.2; 26.2 score on a scale — p=0.02
Advance Care Planning · Palliative Care · Skilled Nursing Facility
Primary: Number of Participants That Completed Patient Quality of Life Survey — 4; 3; 3; 3 Participants
Pain
Primary: Primary Reduction of Pain — 2.55; 1.40 units on a scale from 0 to 10
Liver Cancer · Anxiety Disorder · Depression
Primary: Change in Quality of Life (QOL) From Baseline to Week 12 Per the Functional Assessment of Cancer Therapy-General (FACT-G) — 3.35; 0.12 units on a scale — p=0.104
Cancer · Cardiac Disease · Pulmonary Disease
Primary: Patient Symptom Burden (Edmonton Symptom Assessment Scale [ESAS]) — 35.1; 34.6; 38.6; 38 score on a scale
Advanced Cancer · End Stage Organ Failure
Primary: Change in Quality of Life for Patients, as Measured by the Functional Assessment of Cancer Therapy - General (FACT-G) — 3.7; 3.1 score on a scale
Dementia
Primary: Percentage of Hospice IDT Members Who Complete Required Education and Training — 92 percentage of participants
Acquired Immunodeficiency Syndrome (AIDS)
Primary: Change in Quality of Life — 5.87; 5.17; 5.68; 5.06 score on a scale
Dementia · Chronic Disease · Neoplasm Metastasis
Primary: Proportion of Patients With EHR Documentation of Goals of Care Discussions — 433; 382; 822; 875 Participants — p=0.027
Non-small Cell Lung Cancer · Small Cell Lung Cancer · Mesothelioma
Primary: Functional Assessment of Cancer Therapy (Quality of Life Measure) — 81.10; 77.70 units on a scale
Colonic Neoplasms · Breast Neoplasms · Lung Neoplasms
Primary: Intent to Discuss Advance Directives (Based on the Transtheoretical Stages of Change Model) — 0; 1; 1; 3 Participants
Palliative Medicine · Cardiovascular Disease
Primary: Proportion of Deaths Within 60 Days of Enrollment. — 0.203; 0.238 proportion of deaths
Cancer Metastatic to Lung
Primary: Usability as Measured by the Total Number of Participants Who Complete the Study Questionnaires — 1 Participants
Cancer
Primary: Statement of Treatment Preferences (SOTP) a Tool to Measure Goals of Care. — 10; 22; 38; 19 Dyads — p=<0.05
Cancer
Primary: Number of Study Participants Who Have Completed a Palliative Care Visit Within 3 Months of Enrollment — 22; 130 participants
End Stage Liver Disease
Primary: Patient Satisfaction — 45 Participants
Advanced Cancer
Primary: Change in Prognostic Understanding — 0.00; 0.25 Change in scores on a scale
Palliative Care · Advance Care Planning · Skilled Nursing Facilities
Primary: Number of Participants Who Completed Patient Quality of Life Surveys — 10; 35; 10; 35 participants
Ageing
Primary: World Health Organization Quality of Life-BREF (WHOQOL-BREF) — 86; 82; 3; 3 score on a scale
Pulmonary Disease · COPD · Chronic Bronchitis
Primary: Effect of Intervention on Quality of Patient Clinician Communication About End-of-Life Care(QOC) Scale — 23.3; 19.2; 34.0; 25.5 units on a scale — p=0.03
Hospice
Primary: Participant Recruitment Rate — 37.7 percentage of enrolled participants
Interstitial Lung Disease · Idiopathic Pulmonary Fibrosis
Primary: Number of Participants With ILA (Interstitial Lung Abnormalities) — 85; 13 Participants
Critical Illness · Chronic Disease · Terminal Care
Primary: Occurrence of Discussion About Goals of Care at Target Visit — 137; 66; 47; 145 Participants — p=<0.001
Dementia · Dementia, Vascular · Dementia With Lewy Bodies
Primary: Incidence of Hospital Transfers (Patients) — 0.99; 1.12 events per person day at risk — p=0.522
Dementia · Chronic Disease · Neoplasm Metastasis
Primary: EHR Documentation of Goals of Care Discussions — 0.271; 0.317; 0.206 Proportion of participants — p=0.023
COPD
Primary: Intervention Feasibility — 9.2; 6.4 Sessions
Acute Myeloid Leukemia · Myelodysplastic Syndromes
Primary: Feasibility - Retention Rate — 19; 6; 10 Participants